The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Open accessAbstract
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5-6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.Findings In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0-65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0-199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5-6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5-6, and median CT scores were 3·0 (IQR 2·0-5·0) for severity scale 3, 4·0 (3·0-5·0) for scale 4, and 5·0 (4·0-6·0) for scale 5-6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80-3·25) for scale 4 versus scale 3 and 4·60 (1·85-11·48) for scale 5-6 versus scale 3 for diffusion impairment; OR 0·88 (0·66-1·17) for scale 4 versus scale 3 and OR 1·77 (1·05-2·97) for scale 5-6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58-0·96) for scale 4 versus scale 3 and 2·69 (1·46-4·96) for scale 5-6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m 2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m 2 at follow-up.Interpretation At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.Funding National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Further, severe lung complications from COVID-19 may have persisting limitations to respiratory function and gas exchange; this group of patients, therefore, should be the primary target population for the intervention of long-term recovery.”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“These symptoms can endure up to 6–7 months and even longer [[1], [2], [3], [4], [5]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover [1,16].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Literature data are not equivocal about the association between females and long COVID: some preliminary studies have shown an increased prevalence of fatigue [24] or other symptoms among women [1,5,13,16], while in other studies no gender association was found [4,[18], [19], [20]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
Self-citationWiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,915
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,004
Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design
Oelsner, E. C., Krishnaswamy, A., Balte, P., Allen, N. B., Ali, T., Anugu, P., Andrews, H., Arora, K., Asaro, A., Barr, R. G., et al. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac032 · Cited by 39
Technology adoption and diffusion in healthcare at onset of COVID-19 and beyond
Liu, L., & Cruz, A. M. (2022) · Healthcare Management Forum · doi:10.1177/08404704211058842 · Cited by 39
Cahalan, R., Meade, C., & Mockler, S. (2022) · Canadian Journal of Respiratory Therapy · doi:10.29390/cjrt-2021-074 · Cited by 42
O’Laughlin, K. N., Thompson, M., Hota, B. N., Gottlieb, M. A., Plumb, I. D., Chang, A. M., Wisk, L. E., Hall, A. J., Wang, R. C., Spatz, E. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264260 · Cited by 39
Szeghy, R. E., Stute, N. L., Province, V. M., Augenreich, M. A., Stickford, J. L., Stickford, A. S. L., & Ratchford, S. M. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00793.2021 · Cited by 39
Chudzik, M., Lewek, J., Kapusta, J., Banach, M., Jankowski, P., & Bielecka-Dabrowa, A. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174980 · Cited by 40
Moy, F. M., Hairi, N. N., Lim, E. R. J., & Bulgiba, A. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273364 · Cited by 41
Kalamara, E. I., Pataka, A., Boutou, A., Panagiotidou, E. S., Georgopoulou, A., Ballas, E. T., Chloros, D. A., Metallidis, S., Kioumis, I. P., & Pitsiou, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111909 · Cited by 39
Demographic And Clinical Factors Associated With Long COVID
Song, Z., & Giuriato, M. (2023) · Health Affairs · doi:10.1377/hlthaff.2022.00991 · Cited by 39
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19
Horwitz, L. I., Garry, K., Prete, A. M., Sharma, S., Mendoza, F., Kahan, T. F., Karpel, H. C., Duan, E., Hochman, K. A., & Weerahandi, H. M. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07032-9 · Cited by 38
Alenazy, M. F., Aljohar, H. I., Alruwaili, A. R., Daghestani, M. H., Alonazi, M. A., Labban, R. S. M., El‐Ansary, A. K., & Balto, H. A. G. (2022) · Metabolites · doi:10.3390/metabo12100912 · Cited by 39
Long COVID: what is known and what gaps need to be addressed
Krishna, B. A., Wills, M. R., & Sithole, N. (2023) · British Medical Bulletin · doi:10.1093/bmb/ldad016 · Cited by 40
Bark, L., Larsson, I., Wallin, E., Simrén, J., Zetterberg, H., Lipcsey, M., Frithiof, R., Rostami, E., & Hultström, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-39698-y · Cited by 39
Ida, F. S., Ferreira, H. P., Vasconcelos, A. K. M., Furtado, I. A. B., Fontenele, C. J. P. M., & Pereira, A. C. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xpt026623 · Cited by 47
Research progress of post-acute sequelae after SARS-CoV-2 infection
Jiao, T., Huang, Y., Sun, H., & Yang, L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06642-5 · Cited by 41
Gutman, E. G., Salvio, A. L., Fernandes, R. A., Duarte, L. A., Raposo-Vedovi, J. V., Alcaraz, H. F., Teixeira, M., Passos, G. F., Medeiros, K. Q. M. D., Hämmerle, M. B., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02554-0 · Cited by 39
Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
Lindner, H. A., Velásquez, S. Y., Thiel, M., & Kirschning, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602130 · Cited by 39
Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications?
Wang, J., Mei, F., Bai, L., Zhou, S., Liu, D., Yao, L., Ahluwalia, A., Ghiladi, R. A., Su, L., Shu, T., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.237 · Cited by 38
Self-citationZhu, L., Xu, X. P., Zhu, B., Guo, X., Xu, K., Song, C., Fu, J., Yu, H., Kong, X., Peng, J., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00590-21 · Cited by 38
Skyrud, K. D., Hernæs, K. H., Telle, K. E., & Magnusson, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257926 · Cited by 38
Factors associated with impaired quality of life three months after being diagnosed with COVID-19
Rass, V., Ianosi, B., Zamarian, L., Beer, R., Sahanic, S., Lindner, A., Kofler, M., Schiefecker, A. J., Mahlknecht, P., Heim, B., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02998-9 · Cited by 40
A novel peripheral biomarker for depression and antidepressant response
Targum, S. D., Schappi, J. M., Koutsouris, A., Bhaumik, R., Rapaport, M. H., Rasgon, N., & Rasenick, M. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01399-1 · Cited by 42
Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia
Cocconcelli, E., Bernardinello, N., Giraudo, C., Castelli, G., Giorgino, A., Leoni, D., Petrarulo, S., Ferrari, A. M., Saetta, M. P., Cattelan, A. M., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.823600 · Cited by 38
Beghi, E., Helbok, R., Öztürk, Ş., Karadaş, Ö., Lisnic, V., Grosu, O., Kovács, T., Dobronyi, L., Bereczki, D., Cotelli, M. S., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15293 · Cited by 39
The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review
Brasso, C., Bellino, S., Blua, C., Bozzatello, P., & Rocca, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040772 · Cited by 39
Serum NGF and BDNF in Long-COVID-19 Adolescents: A Pilot Study
Petrella, C., Nenna, R., Petrarca, L., Tarani, F., Paparella, R., Mancino, E., Mattia, G. D., Conti, M. G., Matera, L., Bonci, E., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051162 · Cited by 38
Iob, E., Steptoe, A., & Zaninotto, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200816119 · Cited by 40
Post-COVID-19 Syndrome Mechanisms, Prevention and Management
Najafi, M. B., & Javanmard, S. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_508_21 · Cited by 38
Colas, C., Bayle, M., Labeix, P., Botelho-Nevers, É., Gagneux‐Brunon, A., Cazorla, C., Schein, F., Breugnon, E., Garcin, A., Féasson, L., et al. (2022) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.877188 · Cited by 37
Kawano, Y., Patel, N. J., Wang, X., Cook, C., Vanni, K. M. M., Kowalski, E., Banasiak, E., Qian, G., DiIorio, M. A., Hsu, T. Y. T., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222954 · Cited by 37
Gil, S. D. S., Gualano, B., de Araújo, A. L., Júnior, G. N. D. O., Damiano, R. F., Pinna, F. D. R., Imamura, M., Rocha, V., Kallas, E. G., Battistella, L. R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-26888-3 · Cited by 37
Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
Sibila, O., Albacar, N., Perea, L., Faner, R., Torralba, Y., Hernández‐González, F., Moisés, J., Sánchez-Ruano, N., Aymar, E. S., Badia, J. R., et al. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2021.01.036 · Cited by 37
Gąsecka, A., Pruc, M., Kukula, K., Gilis‐Malinowska, N., Filipiak, K. J., Jaguszewski, M. J., & Szarpak, Ł. (2021) · Cardiology Journal · doi:10.5603/cj.a2021.0028 · Cited by 37
Richter, K., Kellner, S., Hillemacher, T., & Golubnitschaja, O. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00245-2 · Cited by 37
Zhang, Y., Khullar, D., Wang, F., Steel, P. A. D., Wu, Y., Orlander, D., Weiner, M. G., & Kaushal, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255171 · Cited by 37
Fu, Z., Tu, Y., Calhoun, V. D., Zhang, Y., Zhao, Q., Chen, J., Meng, Q., Lu, Z., & Hu, L. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100377 · Cited by 37
Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children
Erol, N., Alpınar, A., Erol, Ç., Sarı, E., & Alkan, K. (2021) · Cardiology in the Young · doi:10.1017/s1047951121003693 · Cited by 37
Och, A., Tylicki, P., Polewska, K., Puchalska-Reglińska, E., Parczewska, A., Szabat, K., Biedunkiewicz, B., Dębska-Ślizień, A. M., & Tylicki, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194451 · Cited by 37
Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic
Mallach, G., Kasloff, S., Kovesi, T. A., Kumar, A., Kulka, R., Krishnan, J., Robert, B., McGuinty, M., den Otter-Moore, S., Yazji, B., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258151 · Cited by 38
Anderson, R. M., Vegvari, C., Hollingsworth, T. D., Pi, L., Maddren, R., Ng, C. W., & Baggaley, R. F. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0008 · Cited by 38
Napolitano, F., Xu, X., & Gao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab456 · Cited by 37
Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Mohamed, M. S., Johansson, A., Jonsson, J., & Schiöth, H. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084275 · Cited by 37
Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment
Imai, K., Yamano, T., Nishi, S., Nishi, R., Nishi, T., Tanaka, H., Tsunoda, T., Yoshimoto, S., Tanaka, A., Hiromatsu, K., et al. (2022) · Viruses · doi:10.3390/v14050907 · Cited by 37
Braga, L. W., de Oliveira, S. B., Moreira, A. S., Pereira, M. E., Carneiro, V. S., Serio, A., Freitas, L. F., Isidro, H. B. L., & Souza, L. M. N. (2022) · Neurorehabilitation · doi:10.3233/nre-228020 · Cited by 40
Kersten, J., Wolf, A., Hoyo, L., Hüll, E., Tadić, M., Andreß, S., d’Almeida, S., Scharnbeck, D., Roder, E., Beschoner, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12839-5 · Cited by 39
Whiteson, J. H., Azola, A. M., Barry, J. T., Bartels, M. N., Blitshteyn, S., Fleming, T. K., McCauley, M. D., Neal, J. D., Pillarisetti, J., Sampsel, S., et al. (2022) · PM&R · doi:10.1002/pmrj.12859 · Cited by 37
Al-Hadrawi, D. S., Al-Rubaye, H. T., Almulla, A. F., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.21 · Cited by 38
Deana, C., Vetrugno, L., Cortegiani, A., Mongodi, S., Salve, G., Mangiagalli, M., Boscolo, A., Pettenuzzo, T., Miori, S., Sanna, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031058 · Cited by 38
Guo, W., Duan, K., Zhang, Y., Yuan, Z., Zhang, Y., Wang, Z., Zhao, D., Zhang, H., Xie, Z., Li, X., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101010 · Cited by 36
Self-citationPneumonia initiates a tauopathy
Balczon, R., Lin, M. T., Lee, J., Abbasi, A. A., Renema, P., Voth, S. B., Zhou, C., Koloteva, A., Francis, C. M., Sodha, N. R., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100718r · Cited by 39
Kuut, T. A., Müller, F., Aldenkamp, A., Assmann-Schuilwerve, E., Braamse, A. M. J., Geerlings, S. E., Gibney, K. B., Kanaan, R., Nieuwkerk, P. T., Hartman, T. O., et al. (2021) · Trials · doi:10.1186/s13063-021-05569-y · Cited by 39
Fortini, A., Rosso, A., Cecchini, P., Torrigiani, A., Forte, A. L., Carrai, P., Alessi, C., Fabbrizzi, F., Lovicu, E., Sbaragli, S., et al. (2022) · Infection · doi:10.1007/s15010-022-01755-5 · Cited by 36
Anjana, N. K. N., Annie, T. T., Shajahan, S., Suresh, M. M., Sujatha, C., & Anish, T. S. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_851_21 · Cited by 36
COVID’s Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us
Patti, K. G., & Kohli, P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01704-6 · Cited by 36
Blackett, J. W., Sun, Y., Purpura, L. J., Margolis, K. G., Elkind, M. S. V., O’Byrne, S. M., Wainberg, M. L., Abrams, J. A., Wang, H. H., Chang, L., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000524 · Cited by 36
Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection
Li, J., Jing, Q., Li, J., Hua, M., Di, L., Song, C., Huang, Y., Wang, J., Chen, C., & Wu, A. R. (2020) · Microbiome · doi:10.1186/s40168-022-01447-0 · Cited by 36
Self-citationOECD (2021) · Health at a glance · doi:10.1787/13aff239-en · Cited by 36
Neurological sequelae of COVID-19: a review
Peterson, C., Sarangi, A., & Bangash, F. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00379-0 · Cited by 36
Noda, Y., Sato, A., Shichi, M., Sato, A., Fujii, K., Iwasa, M., Nagano, Y., Kitahata, R., & Osawa, R. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103438 · Cited by 35
Poyatos, P., Luque, N., Sabater, G., Eizaguirre, S., Bonnin, M., Orriols, R., & Tura-Ceide, O. (2024) · Infection · doi:10.1007/s15010-024-02173-5 · Cited by 35
Doenças crônicas não transmissíveis e covid-19: resultados do estudo Epicovid-19 Brasil
Mesenburg, M. A., Hallal, P. C., Menezes, A. M. B., Barros, A. J. D., Horta, B. L., Barros, F. C., Hartwig, F. P., Jacques, N., & da Silveira, M. F. (2021) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2021055003673 · Cited by 35
Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS
Daher, A., Cornelissen, C. G., Hartmann, N. K., Balfanz, P., Müller, A., Bergs, I., Aetou, M., Marx, N., Marx, G., Simon, T.-P., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115861 · Cited by 35
Horn, A., Krist, L., Lieb, W., Montellano, F. A., Kohls, M., Haas, K., Gelbrich, G., Bolay-Gehrig, S. J., Morbach, C., Reese, J., et al. (2021) · Infection · doi:10.1007/s15010-021-01707-5 · Cited by 36
Jovanoski, N., Chen, X., Becker, U., Zalocusky, K. A., Chawla, D., Tsai, L. W., Borm, M. E. A., Neighbors, M., & Yau, V. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-056284 · Cited by 35
Hayden, M. R., & Tyagi, S. (2021) · Medicina · doi:10.3390/medicina58010016 · Cited by 35
Rodrigues, M., Costa, A. J., Santos, R., Diogo, P., Gonçalves, E. M., Barroso, D., Almeida, M. P., Vaz, I. M., & de Lima, A. K. S. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2032408 · Cited by 35
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19)
Motti, M. L., Tafuri, D., Donini, L. M., Masucci, M. T., Falco, V. D., & Mazzeo, F. (2022) · Nutrients · doi:10.3390/nu14051000 · Cited by 35
Benkalfate, N., Eschapasse, E., Georges, T., Blanc, C. L., Dirou, S., Melscoet, L., Chené, A., Horeau-Langlard, D., Bry, C., Chambellan, A., et al. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001136 · Cited by 35
Qingjin Yiqi granules for post‐COVID‐19 condition: A randomized clinical trial
Pang, W., Yang, F., Zhao, Y., Dai, E., Feng, J., Huang, Y., Guo, Y., Zhou, S., Huang, M. X., Zheng, W., et al. (2022) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12465 · Cited by 35
Self-citationSARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 37
Durstenfeld, M. S., Peluso, M. J., Kelly, J. D., Win, S., Swaminathan, S., Li, D., Arechiga, V. M., Zepeda, V., Sun, K., Shao, S. J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157053 · Cited by 35
del Corral, T., Menor‐Rodríguez, N., Fernández‐Vega, S., Díaz‐Ramos, C., Aguilar‐Zafra, S., & López‐de‐Uralde‐Villanueva, I. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16352 · Cited by 35
Jia, X., Cao, S., Lee, A., Manohar, M., Sindher, S., Ahuja, N. K., Artandi, M. K., Blish, C. A., Blomkalns, A. L., Chang, I., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156713 · Cited by 35
A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID
Imoto, W., Yamada, K., Kawai, R., Imai, T., Kawamoto, K., Uji, M., Kanda, H., Takada, M., Ohno, Y., Ohtani, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25398-6 · Cited by 36
Al‐Hakeim, H. K., Al-Rubaye, H. T., Jubran, A. S., Almulla, A. F., Moustafa, S. R., & Maes, M. H. J. (2023) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-3002 · Cited by 35
Lin, S., Lau, L. H. S., Chanchlani, N., Kennedy, N. A., & Ng, S. C. (2022) · Gut · doi:10.1136/gutjnl-2021-326784 · Cited by 35
Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge
Muñoz-Corona, C., Gutiérrez-Canales, L. G., Ortiz-Ledesma, C., Martínez-Navarro, L. J., Macías, A. E., Scavo-Montes, D. A., & Guaní-Guerra, E. (2022) · Journal of International Medical Research · doi:10.1177/03000605221110492 · Cited by 34
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Zadeh, F. H. (2023) · Archives of Microbiology & Immunology · doi:10.26502/ami.93650103 · Cited by 35
Fernández‐de‐las‐Peñas, C., Gómez‐Mayordomo, V., García‐Azorín, D., Palacios‐Ceña, D., Florêncio, L. L., Peral, Á. L. G., Hernández‐Barrera, V., & Cuadrado, M. L. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.678472 · Cited by 34
Shah, A., Ryu, M. H., Hague, C. J., Murphy, D. T., Johnston, J. C., Ryerson, C. J., Carlsten, C., & Wong, A. W. (2021) · ERJ Open Research · doi:10.1183/23120541.00243-2021 · Cited by 35
Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment
Goel, N., Goyal, N., Nagaraja, R., & Kumar, R. (2021) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2021.1981 · Cited by 34
Persistence of Symptoms After Discharge of Patients Hospitalized Due to COVID-19
Wu, L., Wu, Y., Xiong, H., Mei, B., & You, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.761314 · Cited by 34
Emerging spectrum of post-COVID-19 syndrome
Kunal, S., Madan, M., Tarke, C., Gautam, D. K., Kinkar, J. S., Gupta, K., Agarwal, R., Mittal, S., & Sharma, S. M. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-139585 · Cited by 34
Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome
Jutant, E., Meyrignac, O., Beurnier, A., Jaïs, X., Pham, T. O., Morin, L., Boucly, A., Bulifon, S., Figueiredo, S., Harrois, A., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00479-2021 · Cited by 34
Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19
Knight, D. R. T., Munipalli, B., Logvinov, I. I., Halkar, M. G., Mitri, G., Dabrh, A. M. A., & Hines, S. L. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.01.002 · Cited by 35
Gerganova, A., Assyov, Y. S., & Kamenov, Z. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.826006 · Cited by 34
Bower, J., Radin, A., & Kuhlman, K. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104104 · Cited by 30
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside
Laracy, J. C., Kamboj, M., & Vardhana, S. A. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000841 · Cited by 34
Aouissi, H. A., Ababsa, M., Leveau, C. M., Alexandru-Ionuţ, P., Słomka, A., Kechebar, M. S. A., Yasuhara, J., Epelboin, L., & Ohmagari, N. (2022) · Healthcare · doi:10.3390/healthcare10071341 · Cited by 34
COVID-19 Infections in Gonads: Consequences on Fertility?
Bechmann, N., Macciò, U., Kotb, R. E., Dweik, R. A., Cherfane, M., Moch, H., Bornstein, S. R., & Varga, Z. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1891-6621 · Cited by 34
Chen, Z., Peng, Y., Wu, X., Pang, B., Yang, F., Zheng, W., Liu, C.-X., & Zhang, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.923485 · Cited by 34
Li, Z., He, J., Wang, Y., Bai, M., Zhang, Y., Chen, H., Li, W., Cai, Y., Chen, S., Qu, M., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01484-8 · Cited by 34
Self-citationMatsumoto, K., & Prowle, J. R. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000988 · Cited by 34
Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue
Schlick, S., Lucio, M., Wallukat, G., Bartsch, A., Skornia, A., Hoffmanns, J., Szewczykowski, C., Schröder, T., Raith, F., Rogge, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213683 · Cited by 35
Cortellini, A., Tabernero, J. M., Mukherjee, U., Salazar, R., Sureda, A. M., Maluquer, C., Ferrante, D., Bower, M., Sharkey, R. J., Mirallas, O., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00056-6 · Cited by 34
Hamdh, B. A., & Nazzal, Z. A. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-30583-2 · Cited by 36
Li, T., Zhang, B., Fang, H., Shi, M., Yao, W., Li, Y., Zhang, C., Song, J., Huang, L., Xu, Z., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104600 · Cited by 34
Self-citationKader, M., Hossain, M. A., Reddy, V., Perera, N. K. P., & Rashid, M. (2022) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-022-00451-z · Cited by 33
Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study
Morioka, S., Tsuzuki, S., Maruki, T., Terada, M., Miyazato, Y., Kutsuna, S., Saito, S., Shimanishi, Y., Takahashi, K., Sanada, M., et al. (2023) · Public Health · doi:10.1016/j.puhe.2023.01.008 · Cited by 35
Host genetic polymorphisms involved in long-term symptoms of COVID-19
Udomsinprasert, W., Nontawong, N., Saengsiwaritt, W., Panthan, B., Jiaranai, P., Thongchompoo, N., Santon, S., Runcharoen, C., Sensorn, I., Jittikoon, J., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2239952 · Cited by 33
Metadata
- Authors
- Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D., & Cao, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Jinyintan Hospital (CN)
- Peking University (CN)
- Harbin Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Tsinghua University (CN)
- Corresponding author
- Cao, Bin
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10270
- Pages
- 220-232
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7833295
- OpenAlex
- W3120387768
- Cited by
- 4,084
- References
- 41
- Citations by year
- 2026: 67 · 2025: 180 · 2024: 510 · 2023: 934 · 2022: 1300 · 2021: 1088
- FWCI
- 458.37
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project (2020ZX09201001)
- Chinese Academy of Medical Sciences (2020-I2M-CoV19\u2013005)
- National Natural Science Foundation of China (82041011/H0104)
- National Key Research and Development Program of China (2018YFC1200102)
- China-Japan Friendship Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, long-term health effects, long COVID, fatigue, muscle weakness, sleep disorders, anxiety, depression, disease severity, health-related quality of life, physical function, lung function, SARS-CoV-2, retraction, Wuhan, post-discharge follow-up, risk factors, lopinavir
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Post-Acute COVID-19 Syndrome, Aged, China, Fatigue, Female, Humans, Length of Stay, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sleep Wake Disorders, Cohort Studies, Comorbidity, Muscle Weakness, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
